OM Pharma Scales Globally by Harmonizing Data with Unified RIM

OM Pharma previously managed regulatory information across four disconnected databases, causing data-quality issues and bottlenecks. In March 2022 it consolidated onto Veeva RIM (including Registrations and Submissions) as a single source of truth, streamlining submissions via submission content plans. By April 2025, OM Pharma had added continuous publishing and submitted to Switzerland, Europe, the DACH region, and the USA within two months. Kamal el Bakali, Regulatory Operations Team Lead, is quoted: 'The greatest advantage of Veeva RIM is to have everything in one system. Now we have confidence in our data because it is in one place.'

Veeva Systems is the dominant CRM and content platform in pharma commercial, regulatory, clinical and quality operations, now shipping AI agents directly inside those same production systems.

This sits in the Ship stage of the AI use-case lifecycle: Named examples from the vendors pharma teams use to get an AI system live inside a real, regulated production workflow — validation, CRM, safety and clinical systems of record.